TopiVert Pharma Ltd logo

TopiVert Pharma Ltd

TopiVert is a private, clinical-stage biotechnology company developing next-generation, Non-Systemic Kinase Inhibitors (NSKIs) as novel medicines for the treatment of chronic inflammatory diseases of the gastrointestinal (GI) tract and the eye.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.topivert.com
Founded2011
Disease Focus
Development Stage
STOCK CODENon Listed
Address
52 Princes Gate Exhibition Road, SW7 2PG
London
United Kingdom
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/topivert-pharma-limited” connections=”true” suffix=””]